Last Updated on June 22, 2023

Current Treatment Options in Oncology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Springer New York

Abbreviation: Curr. Treat. Options Oncol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

4.11

SJR

 1.118

h-Index

 60

Rank

 3499

Important Details

Title Current Treatment Options in Oncology
Standard Abbreviation Curr. Treat. Options Oncol.
Type of Publication Journal
Discipline Pharmacology (medical) (Q1); Oncology (Q2)
Impact Score 4.11
SCImago Journal Rank (SJR) 1.118
h-index 60
Overall Rank 3499
Publisher Name Springer New York
Publication Country United States
International Standard Serial Number (ISSN) 15346277, 15272729
Coverage and History 2000-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
1451

About Current Treatment Options in Oncology


Current Treatment Options in Oncology is a journal published by Springer New York. This journal covers the area[s] related to Pharmacology (medical), Oncology, etc. The coverage history of this journal is as follows: 2000-2022. The rank of this journal is 3499. This journal's impact score, h-index, and SJR are 4.11, 60, and 1.118, respectively. The ISSN of this journal is/are as follows: 15346277, 15272729.

The best quartile of Current Treatment Options in Oncology is Q1. This journal has received a total of 1451 citations during the last three years (Preceding 2022).


Current Treatment Options in Oncology Impact Score 2022-2023


The latest impact score (IS) of the Current Treatment Options in Oncology is 4.11. It is computed in the year 2023 as per its definition and based on Scopus data. 4.11

It is decreased by a factor of around 0.94, and the percentage change is -18.61% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Current Treatment Options in Oncology Impact Score 2023


Impact Score 2022 of Current Treatment Options in Oncology is 4.11. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Current Treatment Options in Oncology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 4.11
2021 5.05
2020 4.75
2019 3.92
2018 4.17
2017 4.02
2016 3.37
2015 2.78
2014 3.64

Current Treatment Options in Oncology h-index


  Table Setting

The h-index of Current Treatment Options in Oncology is 60. By definition of the h-index, this journal has at least 60 published articles with more than 60 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Current Treatment Options in Oncology ISSN


The International Standard Serial Number (ISSN) of Current Treatment Options in Oncology is/are as follows: 15346277, 15272729.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Current Treatment Options in Oncology Ranking and SCImago Journal Rank (SJR)


The Current Treatment Options in Oncology is ranked 3499 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.118.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Current Treatment Options in Oncology Publisher


Table Setting

The publisher of Current Treatment Options in Oncology is Springer New York. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2000-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Current Treatment Options in Oncology is Curr. Treat. Options Oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Curr. Treat. Options Oncol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Current Treatment Options in Oncology


If your area of research or discipline is related to Pharmacology (medical), Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Current Treatment Options in Oncology?

The latest impact score of Current Treatment Options in Oncology is 4.11. It is computed in the year 2023.


What is the h-index of Current Treatment Options in Oncology?

The latest h-index of Current Treatment Options in Oncology is 60. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Current Treatment Options in Oncology?

The latest SCImago Journal Rank (SJR) of Current Treatment Options in Oncology is 1.118. It is calculated in the year 2023.


What is the ranking of Current Treatment Options in Oncology?

The latest ranking of Current Treatment Options in Oncology is 3499. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Current Treatment Options in Oncology?

Current Treatment Options in Oncology is published by Springer New York. The publication country of this journal is United States.


What is the abbreviation of Current Treatment Options in Oncology?

This standard abbreviation of Current Treatment Options in Oncology is Curr. Treat. Options Oncol..


Is "Current Treatment Options in Oncology" a Journal, Conference or Book Series?

Current Treatment Options in Oncology is a journal published by Springer New York.


What is the scope of Current Treatment Options in Oncology?

The scope of Current Treatment Options in Oncology is as follows:

  • Pharmacology (medical)
  • Oncology

For detailed scope of Current Treatment Options in Oncology, check the official website of this journal.


What is the ISSN of Current Treatment Options in Oncology?

The International Standard Serial Number (ISSN) of Current Treatment Options in Oncology is/are as follows: 15346277, 15272729.


What is the best quartile for Current Treatment Options in Oncology?

The best quartile for Current Treatment Options in Oncology is Q1.


What is the coverage history of Current Treatment Options in Oncology?

The coverage history of Current Treatment Options in Oncology is as follows 2000-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Applied Ecology and Environmental Research Journal Corvinus University of Budapest 17545 38 0.74
Archives of Phytopathology and Plant Protection Journal Taylor and Francis Ltd. 14852 29 1.14
Mathematical Modelling and Analysis Journal Vilnius Gediminas Technical University 11315 27 1.75
Journal of Classical Sociology Journal SAGE Publications Ltd 13766 27 0.83
International Journal of Applied Linguistics Journal Wiley-Blackwell Publishing Ltd 7321 51 2.00
Transnational Corporations Journal UNCTAD United Nations Conference on Trade and Development 6120 27 1.92
Tekstilec Trade Journal Faculty of Natural Sciences and Engineering, Tekstilec 19217 14 0.73
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
Journal on Chain and Network Science Journal Wageningen Academic Publishers 11905 24 0.00
International Journal of Advertising Journal Taylor and Francis Ltd. 1226 74 8.22

Check complete list




Current Treatment Options in Oncology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 4.11
2021 5.05
2020 4.75
2019 3.92
2018 4.17
2017 4.02
2016 3.37
2015 2.78
2014 3.64



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All